BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28726173)

  • 21. Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.
    Heiland DH; Masalha W; Franco P; Machein MR; Weyerbrock A
    J Neurooncol; 2016 Feb; 126(3):567-75. PubMed ID: 26614518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.
    Stark AM; van de Bergh J; Hedderich J; Mehdorn HM; Nabavi A
    Clin Neurol Neurosurg; 2012 Sep; 114(7):840-5. PubMed ID: 22377333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma.
    Bir SC; Connor DE; Ambekar S; Wilden JA; Nanda A
    Neurosurg Rev; 2015 Oct; 38(4):705-13. PubMed ID: 25864406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat-surgery at Glioblastoma recurrence, when and why to operate?
    Ening G; Huynh MT; Schmieder K; Brenke C
    Clin Neurol Neurosurg; 2015 Sep; 136():89-94. PubMed ID: 26092644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions.
    Anselmo P; Maranzano E; Selimi A; Lupattelli M; Palumbo I; Bini V; Casale M; Trippa F; Bufi A; Arcidiacono F; Aristei C
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):273-279. PubMed ID: 33078909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological findings and prognostic factors in recurrent glioblastomas.
    Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Kayama T; Shibui S
    Brain Tumor Pathol; 2012 Oct; 29(4):192-200. PubMed ID: 22331317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for glioblastoma therapy associated complications.
    Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
    Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent glioblastoma: who receives tumor specific treatment and how often?
    Steffens R; Semrau S; Lahmer G; Putz F; Lettmaier S; Eyüpoglu I; Buchfelder M; Fietkau R
    J Neurooncol; 2016 May; 128(1):85-92. PubMed ID: 26907492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients.
    Socha J; Kepka L; Ghosh S; Roa W; Kumar N; Sinaika V; Matiello J; Lomidze D; de Castro DG; Hentati D; Fidarova E
    J Neurooncol; 2016 Feb; 126(3):493-8. PubMed ID: 26542030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Ellsworth S; Ye X; Grossman SA
    Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.
    Badaoui N; Meyronet D; Cartalat-Carel S; Guyotat J; Jouanneau E; d'Hombres A; Sunyach MP; Jouvet A; Louis-Tisserand G; Archinet A; Frappaz D; Bauchet L; Honnorat J; Ducray F
    Rev Neurol (Paris); 2014 Mar; 170(3):222-7. PubMed ID: 24582303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioblastoma in the elderly: the impact of advanced age on treatment and survival.
    Mariniello G; Peca C; De Caro Mdel B; Giamundo A; Donzelli R; Maiuri F
    J Neurol Surg A Cent Eur Neurosurg; 2014 Jul; 75(4):276-81. PubMed ID: 24390930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
    Taal W; Oosterkamp HM; Walenkamp AM; Dubbink HJ; Beerepoot LV; Hanse MC; Buter J; Honkoop AH; Boerman D; de Vos FY; Dinjens WN; Enting RH; Taphoorn MJ; van den Berkmortel FW; Jansen RL; Brandsma D; Bromberg JE; van Heuvel I; Vernhout RM; van der Holt B; van den Bent MJ
    Lancet Oncol; 2014 Aug; 15(9):943-53. PubMed ID: 25035291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
    Weinberg BD; Boreta L; Braunstein S; Cha S
    J Neurooncol; 2018 Jul; 138(3):549-556. PubMed ID: 29546530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
    Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
    Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.